Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study. // NeuroMarkers. – URL: https://www.sciencedirect.com/science/article/pii/S2950588726000327?dgcid=rss_sd_all
Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study. NeuroMarkers. https://www.sciencedirect.com/science/article/pii/S2950588726000327?dgcid=rss_sd_all
“Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study.” NeuroMarkers.
@article{article90297,
title = {Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study},
journal = {NeuroMarkers},
url = {https://www.sciencedirect.com/science/article/pii/S2950588726000327?dgcid=rss_sd_all}
}